Back to Blog
Beem earnings6/13/2023 ![]() All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Please note this is an estimate earnings date, companies may might revise. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. When will BEEM report earnings - BEEM earnings date is on Monday, May 15, 2023. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. ![]() Factset: FactSet Research Systems Inc.2019. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself.Most stock quote data provided by BATS. Simply Wall St has no position in any stocks mentioned. The Company develops, manufactures and sells renewably energized infrastructure products for electric vehicle charging infrastructure, energy storage, energy security, disaster preparedness and outdoor media advertising. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Beam Global is a clean-technology company. Beam Global (BEEM) (Real Time Quote from BATS) 11.80 USD -0.28 (-2.32) Updated 11:04 AM ET Add to portfolio Zacks Rank: 4-Sell 4 Style Scores: F Value F Growth A Momentum F. ![]() We aim to bring you long-term focused analysis driven by fundamental data. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. Earnings Summary For their last quarter, Beam Global (BEEM) reported earnings of -0.77 per share, missing the Zacks Consensus Estimate of -0.45 per share. This article by Simply Wall St is general in nature. Earnings Press Release 10-Q Quarterly Report 10-Q QoQ Changes. Alternatively, email editorial-team (at) . Beam Global (BEEM) SEC Filing 10-Q Quarterly Report for the period ending Thursday. 12 Mln Price to Earnings price-to-earning. Have feedback on this article? Concerned about the content? Get in touch with us directly. Get Beam Global (BEEM)s stock analysis, price valuation, corporate actions, and financials from Indias. You still need to take note of risks, for example - CRISPR Therapeutics has 1 warning sign we think you should be aware of. The company's shares are up 32% from a week ago. Earnings Summary For their last quarter, Beam Global (BEEM) reported earnings of -0.77 per share, missing the Zacks Consensus Estimate of -0.45 per share. Performance of the American Biotechs industry. , which belongs to the Zacks Automotive - Original Equipment industry, posted revenues of 452.16 million for the quarter ended March 2023, surpassing the Zacks. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US. Looking ahead, revenue is forecast to grow 58% p.a. (BEAM) delivered earnings and revenue surprises of 2.21 and 67.99, respectively, for the quarter ended March 2023. Earnings per share (EPS) also surpassed analyst estimates by 59%. BEEM Price, Volume, Earnings, and Dividend Date Last Price 8.62 Previous Close 8.79 Change -0.17 Open 8.73 Volume 115,044 Avg. Revenue exceeded analyst estimates significantly. ![]() Beam Global (BEEM) Q4 2022 Earnings Call Transcript. Revenues for the fourth fiscal quarter of 2022 set a new record for. See real time price charts for BEEM stock, historical data, and recent news. CRISPR Therapeutics Revenues and Earnings Beat Expectations Next, I would like to provide an overview of our financial results for Beam's fourth quarter and year ended December 31, 2022. ![]()
0 Comments
Read More
Leave a Reply. |